The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

Cenerimod is a novel oral S1P1 receptor modulator with potential to be a first- or best-in-class therapy for multiple autoimmune diseasesViatris ...

A1,("Cathode Powder and Processes)," describes a method for producing lithium iron phosphate (LFP) cathode materials for the ...

Tesla has published a new 100 page patent that describes an innovation for making cathode powder with wet and dry processes. Drew Banglino, x-Tesla executive, ...

Forward Medical, a leading innovator in plastic surgery, aesthetic surgery, and dermatology products, participated in the ...

BEIJING -- The average review time for invention patents in China has been reduced to 15.5 months, according to the China National Intellectual Property Administration (CNIPA). The CNIPA also noted ...

Patents require reliability so they can incentivize investments in new technologies, their primary though little-noticed ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...